Veeva Systems Inc.

Veeva Systems Inc. (NYSE: VEEV) is the leading provider of industry cloud solutions for the global life sciences industry. The company's website is veeva.com. Veeva delivers a comprehensive suite of cloud-based software, data, and business consulting services designed to support pharmaceutical, biotechnology, and medical device companies throughout their product development, manufacturing, quality, and commercialization processes.

The company operates through two primary business segments. Commercial Solutions, which includes Veeva Commercial Cloud and Veeva Data Cloud, serves the sales, marketing, and medical affairs functions of life sciences companies. R&D and Quality Solutions, encompassing Veeva Development Cloud and Veeva Quality Cloud, supports clinical research, regulatory affairs, safety management, and quality operations. In fiscal year 2026, the top 10 customers accounted for 28 percent of total revenues, with customers outside North America representing approximately 40 percent of revenues.

Veeva's core platform, Veeva Vault, provides a unified content and data management foundation supporting multiple integrated applications. The company's product portfolio includes Vault CRM for customer relationship management, clinical trial management solutions, regulatory information management, quality management systems, and advanced data analytics platforms. Veeva also offers professional services and business consulting to help customers maximize solution value and optimize their business processes.

As of January 31, 2026, Veeva served 1,552 customers ranging from the largest global pharmaceutical companies to emerging biotechnology firms. The company employed 7,928 people worldwide across operations in the United States, European Union, Japan, South Korea, Singapore, Australia, Brazil, and China. Veeva maintains a quality management system certified to ISO 9001 and operates under rigorous compliance standards including FDA regulations, EU GMP requirements, and HIPAA privacy standards.

The company is structured as a Delaware public benefit corporation, reflecting its commitment to balancing stockholder returns with benefits to customers, employees, partners, and communities. Veeva's competitive advantages include deep domain expertise in life sciences, a modern multitenant cloud architecture, an extensive patent portfolio, and a strong customer base that provides reference selling opportunities for new market expansion.